Limited access

Upgrade to access all content for this subject

Use the information below, as well as the previous passages, to answer this question.

DNA sequences lead to the production of proteins through a two-step process. The first step is called transcription. During transcription, the DNA strands are copied into a piece of RNA one base at a time. This copy travels out of the nucleus to the cytoplasm. Here the second step will begin, called translation. During translation, the RNA will put the building blocks of proteins, called amino acids, together in the right order so that a proper protein can be produced.

Another line of research has focused on a protein called Apolipoprotein E (APOE). The gene for APOE is found on human chromosome #19. Sequence analysis shows that the APOE protein comes in several different forms, which geneticists call alleles. Three alleles occur in humans: APOE 2, APOE 3, and APOE 4. This protein, in its normal form, is known to clean cholesterol and other types of fat away from neurons, helping them to stay healthy and function properly. The APOE proteins are under study at this point to see if there is a link between any of them and early and late onset Alzheimer’s disease. For this study, the research team looked at gene sequences from 1000 individuals. A summary of their findings is in the chart below:

Allele # in Population # with Early Onset Average Age of Early Onset Diagnosis # with Late Onset Average Age of Late Onset Diagnosis
APOE 2 120 2 39 12 73
APOE 3 750 12 32 32 62
APOE 4 130 9 33 71 60

Alzheimer’s disease is an irreversible, progressive brain disease that is characterized by the development of brain lesions (known as plaques) and tangles in the delicate fibers of the nerve tissue. This causes the loss of connections between neurons, the specialized cells of the nervous system, and the eventual death of these cells. Scientists have long known that neurons are highly specialized cells. They have a streamlined design, giving them the ability to quickly conduct electrical messages as the body responds to changes in its environment. This specialization comes at a price, however, as these neurons can only make repairs to themselves if the damage is slight. Once damaged beyond repair, or dead, these cells can’t regenerate, leaving the victim lacking a sufficient number of vital neurons.

There are two types of Alzheimer’s disease: early onset, and late onset. Early onset occurs in people age 30 to 60. It is the rarer form of the disease, representing less than 5% of the people who contract it. Most cases of Alzheimer’s are of the late onset form, which develops after age 60. The causes of both diseases are still being worked out. Much research has been done, including a hunt for a possible genetic connection that may be the root cause of the disease. Scientists are looking at genes, sequences of DNA which code for the making of proteins, as possible contributors to both varieties of Alzheimer’s. Researchers first asked if perhaps victims have faulty DNA which could be causing their condition. Scientists pinpointed a specific neuron protein on Chromosome #21 that may lead to Alzheimer’s. It is called amyloid precursor protein (APP).

Researchers studied APP DNA sequences, making comparisons between people who have both types of Alzheimer’s, as well as people who don’t. The results of the sequence analysis are shown in the table below:

Patient Type Age Partial AAP Gene Sequence From Chromosome #21
Non-Alzheimer's Male 35 AAC/CGG/TTA/CGC/ATT/GTG/CCA/TTA
Non-Alzheimer's Male 70 ACC/CGG/TTA/CGC/ATT/GTG/CCA/TTA
Non-Alzheimer's Female 35 AAC/CGG/TTA/CGC/ATT/GTG/CCA/TTA
Non-Alzheimer's Female 70 ACC/CGG/TTA/CGC/ATT/GTG/CCA/TTA

Based on all the information presented, how might a team of researchers go about curing victims of either early or late onset Alzheimer’s disease?


Place mutated APP gene sequences into the cells of victims of Alzheimer’s. This will allow the cells to make proteins to treat the disease.


Use a combination of APP protein and copies of the protein made from the APOE 4 allele to treat people with the disease.


Make copies of the protein produced by the APOE 2 allele and give it to victims of the disease.


Develop a vaccine using the APOE 3 allele as a model to treat people who already have either variety of the disease.

Select an assignment template